June 10, 2003; 60 (11 suppl 4) Articles
Conversion to monotherapy
Clinical trials in patients with refractory partial seizures
Ahmad Beydoun, Ekrem Kutluay
First published June 10, 2003, DOI: https://doi.org/10.1212/WNL.60.11_suppl_4.S13
Conversion to monotherapy
Clinical trials in patients with refractory partial seizures
Ahmad Beydoun, Ekrem Kutluay
Neurology Jun 2003, 60 (11 suppl 4) S13-S25; DOI: 10.1212/WNL.60.11_suppl_4.S13
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 60 no. 11 suppl 4 S13-S25
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published June 10, 2003.
Copyright & Usage:
© 2003
Author Disclosures
- Ahmad Beydoun, MD and
- Ekrem Kutluay, MD
- Ahmad Beydoun, MD and
- Ekrem Kutluay, MD
- Address correspondence and reprint requests to Dr. Ahmad Beydoun, Department of Neurology, University of Michigan Health System, UH1B300/0036, Ann Arbor, MI 48109.
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Abstract
- Historical perspectives on the design of conversion-to-monotherapy trials.
- Outpatient conversion to monotherapy trials.
- Results of outpatient conversion to monotherapy trials.
- Advantages and shortcomings of outpatient conversion to monotherapy trials.
- Presurgical conversion to monotherapy trials.
- Results of presurgical conversion to monotherapy trials.
- Advantages and shortcomings of presurgical conversion to monotherapy trials.
- Conclusions.
- Footnotes
- References
- Figures & Data
- Info & Disclosures
Advertisement
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Oxcarbazepine adjunctive therapy in infants and young children with partial seizuresJ. E. Piña-Garza, R. Espinoza, D. Nordli et al.Neurology, November 07, 2005 -
Articles
Oxcarbazepine monotherapy for partial-onset seizuresA multicenter, double-blind, clinical trialA. Beydoun, R.C. Sachdeo, W.E. Rosenfeld et al.Neurology, June 27, 2000 -
Articles
Monotherapy clinical trial designRajesh Sachdeo et al.Neurology, December 10, 2007 -
Articles
Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizuresR. Sachdeo, A. Beydoun, S. Schachter et al.Neurology, September 11, 2001